Palifermin use in children and adolescents undergoing allogeneic hematopoietic stem cell transplantation
Journal Title: Postępy Nauk Medycznych - Year 2013, Vol 26, Issue 9
Abstract
Introducton. Palifermin, a recombinant human keratinocyte growth factor, is used in adults to prevent oral mucositis following allogeneic stem cell transplantation. Palifermin decreases total parenteral nutrition, length of initial hospital stay and opioid usage in pain control caused by oral mucositis in adults.Aim. The objective of this prospective study was the analysis of safety and efficacy of palifermin in children and adolescents.Material and methods. Seventy-nine consecutive patients undergoing allogeneic stem cell transplantation and treated with palifermin were included into the study. The results of efficacy were compared to data of 32 patients, not treated with palifemin.Results. Palifermin decreased incidence of severe oral mucositis (grade 3 and 4 WHO), acute graft versus host disease (≥ 2 grade), chronic graft versus host disease, and opioid usage in pain control caused by oral mucositis. Palifermin did not affect time of total parenteral nutrition. Adverse events of palifermin use were observed only in one patient as generalized itch and erythema. Data obtained in particular subgroups: type of donor (sibling vs alternative) or type of conditioning (chemotherapy vs TBI-based) reached different statistical significance level, what was limited by number of patients in particular subgroups.Conclusions. Palifermin is a safe drug when used in children and adolescents undergoing allogeneic stem cell transplantation. The use of this drug leads to significant decrease of mucosal toxicity and frequency of acute and chronic GVHD.
Authors and Affiliations
Krzysztof Czyżewski, Jan Styczyński, Robert Dębski, Anna Kręska, Mariusz Wysocki
Keywords
Related Articles
- EP ID EP54793
- DOI -
- Views 146
- Downloads 0
Miejsce dla uzupełniającego leczenia mitotanem u pacjentów niskiego ryzyka z rakiem kory nadnercza – opis przypadku
Przedstawiamy przypadek 56-letniej kobiety leczonej z powodu nadciśnienia tętniczego z guzem prawego nadnercza potwierdzonym w badaniu TK jamy brzusznej w 2006 roku wielkości 16 x 18 mm i gęstością przed podaniem kontras...
Transforming growth factor β1 as an indicator of the progression of chronic viral hepatitis
Transforming growth factor b1 (TGF b1) is main cytokine responsible for progression of fibrosis in chronic liver disease. Factors having impact on progression in chronic viral hepatitis (cvh) are not clearly identified.T...
Evaluation of the efficacy of intravenous corticotherapy in preventing exacerbation of thyroid orbitopathy in patients with Graves’ disease treated with radioactive iodine due to hyperthyroidism
<b>Introduction.</b> Radioiodine treatment of thyrotoxicosis in Graves’ disease patients may lead to orbitopathy progression. Oral glucocorticoid therapy is a standard method in...
The incidence and type of symptoms of respiratory disorders during sleep in children aged 6-12 years in parents report – own research
Introduction. Sleep disorders of breathing (SDB) in children is a clinical problem that is nowadays becoming well recognized both by patients and doctors. It can be the basis for the diagnosis of Obturative Sleep Apnea S...
Bladder cancer in Poland
<b>Introduction. </b>Bladder cancer (BCa) is 3<sup>rd</sup> most common cancer in men and 15<sup>th</sup> in women in Poland. The costs...